Rani Therapeutics Holdings (RANI) Tax Provisions (2020 - 2022)

Rani Therapeutics Holdings has reported Tax Provisions for 3 years, with the latest figure at -$11000.0 in Q4 2022.

• On a quarterly basis, Tax Provisions rose 72.5% year-over-year to -$11000.0 in Q4 2022; TTM through Dec 2023 was -$11000.0, a 111.0% decrease from a year earlier, with the FY2022 full-year figure at $100000.0, up 143.9% from the prior year.
• Tax Provisions was -$11000.0 for Q4 2022 at Rani Therapeutics Holdings, up from -$106000.0 in the prior quarter.
• The five-year high for Tax Provisions was $154000.0 in Q2 2022, with the low at -$106000.0 in Q3 2022.
• Average Tax Provisions over 3 years is $14909.1, with a median of $6000.0 recorded in 2020.
• The sharpest annual moves came in 2021 and 2022: Tax Provisions sank 433.33% in 2021, then soared 15300.0% in 2022.
• Over 3 years, Tax Provisions stood at $12000.0 in 2020, then tumbled by 433.33% to -$40000.0 in 2021, then surged by 72.5% to -$11000.0 in 2022.
• The last three Tax Provisions figures came in at -$11000.0 (Q4 2022), -$106000.0 (Q3 2022), and $154000.0 (Q2 2022), per Business Quant data.